JTT 551

Drug Profile

JTT 551

Alternative Names: JTT-551

Latest Information Update: 15 Aug 2007

Price : $50

At a glance

  • Originator Japan Tobacco
  • Class Antihyperglycaemics
  • Mechanism of Action Protein-tyrosine-phosphatase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 09 Aug 2007 Discontinued - Phase-I for Type-2 diabetes mellitus (PO)
  • 09 Aug 2007 Discontinued - Phase-I for Type-2 diabetes mellitus in Japan (PO)
  • 31 Oct 2006 Phase-I clinical trials in Type-2 diabetes mellitus (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top